BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32890192)

  • 1. Development of the Emergency Services Swab Resource Team During COVID-19.
    Hamm R; Komansky B; Beck E
    J Nurses Prof Dev; 2020; 36(5):317. PubMed ID: 32890192
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19: Nasal and oropharyngeal swab.
    Petruzzi G; De Virgilio A; Pichi B; Mazzola F; Zocchi J; Mercante G; Spriano G; Pellini R
    Head Neck; 2020 Jun; 42(6):1303-1304. PubMed ID: 32352180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal Swab as Preferred Clinical Specimen for COVID-19 Testing in Children.
    Palmas G; Moriondo M; Trapani S; Ricci S; Calistri E; Pisano L; Perferi G; Galli L; Venturini E; Indolfi G; Azzari C
    Pediatr Infect Dis J; 2020 Sep; 39(9):e267-e270. PubMed ID: 32618933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring alternative swabs for use in SARS-CoV-2 detection from the oropharynx and anterior nares.
    Patriquin G; Davis I; Heinstein C; MacDonald J; Hatchette TF; LeBlanc JJ
    J Virol Methods; 2020 Nov; 285():113948. PubMed ID: 32783913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious Diseases Diagnoses of Children Admitted With Symptoms of Coronavirus Disease 2019 During an Outbreak in New York City.
    Acker KP; Schertz K; Abramson EL; DeLaMora P; Salvatore CM; Han JY
    Clin Pediatr (Phila); 2020 Dec; 59(14):1293-1295. PubMed ID: 32713187
    [No Abstract]   [Full Text] [Related]  

  • 6. A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2.
    LeBlanc JJ; Heinstein C; MacDonald J; Pettipas J; Hatchette TF; Patriquin G
    J Clin Virol; 2020 Jul; 128():104442. PubMed ID: 32540034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Nasopharyngeal Swab Comparable With Nasopharyngeal Aspirate to Detect SARS-CoV-2 in Children?
    Capecchi E; Di Pietro GM; Luconi E;
    Pediatr Infect Dis J; 2020 Sep; 39(9):e288-e289. PubMed ID: 32740453
    [No Abstract]   [Full Text] [Related]  

  • 8. Necessity for detection of SARS-CoV-2 RNA in multiple types of specimens for the discharge of the patients with COVID-19.
    Tong Y; Bao A; Chen H; Huang J; Lv Z; Feng L; Cheng Y; Wang Y; Bai L; Rao W; Zheng H; Wu Z; Qiao B; Zhao Z; Wang H; Li Y
    J Transl Med; 2020 Nov; 18(1):411. PubMed ID: 33138834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and emergency surgery.
    Hogan A
    Br J Surg; 2020 Jun; 107(7):e180. PubMed ID: 32329524
    [No Abstract]   [Full Text] [Related]  

  • 10. Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus (SARS-CoV-2) safely: How to dress, undress, and technical notes.
    Di Maio P; Iocca O; Cavallero A; Giudice M
    Head Neck; 2020 Jul; 42(7):1548-1551. PubMed ID: 32357377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. India under COVID-19 lockdown.
    The Lancet
    Lancet; 2020 Apr; 395(10233):1315. PubMed ID: 32334687
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 swab collection and serological screening in lipoprotein apheresis unit.
    Sbrana F; Dal Pino B; Bigazzi F; Pianelli M; Luciani R; Sampietro T
    J Clin Apher; 2020 Aug; 35(4):382-383. PubMed ID: 32629544
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens.
    Hou H; Chen J; Wang Y; Lu Y; Zhu Y; Zhang B; Wang F; Mao L; Tang YW; Hu B; Ren Y; Sun Z
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32503847
    [No Abstract]   [Full Text] [Related]  

  • 14. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.
    Kumar K; Prakash AA; Gangasagara SB; Rathod SBL; Ravi K; Rangaiah A; Shankar SM; Basawarajappa SG; Bhushan S; Neeraja TG; Khandenahalli S; Swetha M; Gupta P; Sampritha UC; Prasad GNS; Jayanthi CR
    Indian J Ophthalmol; 2020 Jun; 68(6):1015-1017. PubMed ID: 32461418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Challenges of Expanding Rapid Tests to Curb COVID-19.
    Rubin R
    JAMA; 2020 Nov; 324(18):1813-1815. PubMed ID: 33084882
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 in Canada: Experience and Response.
    Detsky AS; Bogoch II
    JAMA; 2020 Aug; 324(8):743-744. PubMed ID: 32790824
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishing a healthcare worker screening programme for COVID-19.
    Boustead K; McDowall K; Baker KF; Pareja-Cebrian L; Gibson L; Cunningham M; Murphy E
    Occup Med (Lond); 2020 Oct; 70(7):456-457. PubMed ID: 32569369
    [No Abstract]   [Full Text] [Related]  

  • 18. Covid-19: testing times.
    Beeching NJ; Fletcher TE; Beadsworth MBJ
    BMJ; 2020 Apr; 369():m1403. PubMed ID: 32269032
    [No Abstract]   [Full Text] [Related]  

  • 19. The Sampling Locations are Closely Related to the Positive Rate of Novel Coronavirus Nucleic Acid Detection.
    Wang D; Wang H; Li S; Ren T; Cao Z; Nie H; Chen Z; Ma W; Wu Y; Chen Z; Huang T; Song C; Zhou Y
    Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538065
    [No Abstract]   [Full Text] [Related]  

  • 20. Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview.
    See A; Toh ST
    Head Neck; 2020 Jul; 42(7):1652-1656. PubMed ID: 32357381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.